Toronto Dominion Bank acquired a new position in athenahealth, Inc. (NASDAQ:ATHN) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 120,000 shares of the health services provider’s stock, valued at approximately $16,863,000. Toronto Dominion Bank owned about 0.30% of athenahealth at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. FMR LLC boosted its holdings in athenahealth by 0.8% in the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares during the last quarter. Janus Henderson Group PLC acquired a new stake in athenahealth in the 2nd quarter worth about $713,856,000. Vanguard Group Inc. boosted its holdings in athenahealth by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares during the last quarter. Capital Research Global Investors boosted its holdings in athenahealth by 15.5% in the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock worth $286,963,000 after buying an additional 273,660 shares during the last quarter. Finally, BlackRock Inc. boosted its holdings in athenahealth by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock worth $229,377,000 after buying an additional 32,146 shares during the last quarter.

In other athenahealth news, SVP Jonathan D. Porter sold 422 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $154.00, for a total transaction of $64,988.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Daniel P. Haley sold 1,583 shares of the stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $124.56, for a total transaction of $197,178.48. Following the transaction, the insider now directly owns 13,408 shares in the company, valued at approximately $1,670,100.48. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,505 shares of company stock worth $2,240,851. 3.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “120,000 Shares in athenahealth, Inc. (ATHN) Acquired by Toronto Dominion Bank” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/10/15/120000-shares-in-athenahealth-inc-athn-acquired-by-toronto-dominion-bank.html.

Several equities research analysts recently issued reports on ATHN shares. ValuEngine upgraded athenahealth from a “sell” rating to a “hold” rating in a report on Monday, July 24th. Evercore ISI reiterated an “outperform” rating and issued a $163.00 price objective (up from $155.00) on shares of athenahealth in a report on Saturday, July 22nd. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and lifted their price objective for the stock from $127.00 to $133.00 in a report on Monday, July 31st. Jefferies Group LLC reiterated a “hold” rating and issued a $135.00 price objective on shares of athenahealth in a report on Monday, June 26th. Finally, KeyCorp reiterated a “buy” rating and issued a $170.00 price objective on shares of athenahealth in a report on Sunday, September 17th. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and twelve have assigned a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus target price of $149.48.

Shares of athenahealth, Inc. (ATHN) traded down 4.60% during mid-day trading on Friday, reaching $115.42. The company’s stock had a trading volume of 1,823,004 shares. athenahealth, Inc. has a 1-year low of $90.11 and a 1-year high of $158.66. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of 146.47 and a beta of 1.76. The firm’s 50 day moving average price is $127.86 and its 200-day moving average price is $130.20.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.12. The company had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. athenahealth’s revenue was up 15.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.34 earnings per share. On average, analysts predict that athenahealth, Inc. will post $1.91 EPS for the current year.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.